tamoxifen agent binds intracytoplasmic estrogen receptors evaluated possible means increasing alpha 1at synthesis secretion alpha 1at serum levels subjects homozygous form alpha 1at deficiency administration tamoxifen NUMBER mg twice daily NUMBER z homozygotes period associated adverse reactions serum alpha 1at levels increased significantly p NUMBER increase minor average pretreatment levels NUMBER NUMBER levels NUMBER days therapy NUMBER NUMBER far threshold level NUMBER considered protective increased risk emphysema concept increasing alpha 1at synthesis secretion rational goal treating z homozygous form alpha 1at deficiency tamoxifen useful regard alpha NUMBER antitrypsin NUMBER day mg dl mg dl mg dl